Article
Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing.
PloS one - 1 Jan 2012
Lataillade Max, Chiarella Jennifer, Yang Rong, DeGrosky Michelle, Uy Jonathan, Seekins Daniel, Simen Birgitte, St John Elizabeth, Moreno Elizabeth, Kozal Michael
Abstract excerpt
BACKGROUND: It is unknown whether HIV-positive patients experiencing virologic failure (VF) on boosted-PI (PI/r) regimens without drug resistant mutations (DRM) by standard genotyping harbor low-level PI resistant variants. CASTLE compared the efficacy of atazanavir/ritonavir (ATV/r) with lopinavir/ritonavir (LPV/r), each in combination with TVD in ARV-naïve subjects. OBJECTIVE: To determine if VF on an initial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
